drugset / Trial / NCT00092131

Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270)

NCT00092131

Phase 3 Completed 51 enrolled Organon and Co
RandomizedCrossoverDouble-blindPrevention

Summary

The purpose of this study is to determine the effect of an approved medication being studied in support of a new approach in the prevention of exercise-induced asthma (a worsening of asthma caused by exercise, also known as exercise-induced bronchospasm), in participants who have a history of worsening asthma after exercise.

Timeline

Start
2003-06
Primary completion
2003-11
Completion
2003-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 10 mg Oral